{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:06:58Z","timestamp":1791446818118,"version":"4.3.3"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.thromres.2016.11.021","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T12:15:31Z","timestamp":1480076131000},"page":"104-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial"],"prefix":"10.1016","volume":"150","author":[{"given":"Sulman","family":"Rafiq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Andreas","family":"Steinbr\u00fcchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaj Bang","family":"Lille\u00f8r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Holdflod","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Teglgaard","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Juel","family":"Thiis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"K\u00f8ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Skov","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.thromres.2016.11.021_bb0005","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/CIR.0000000000000029","article-title":"Thomas JD; ACC\/AHA task force members. 2014 AHA\/ACC guideline for the Management of Patients with Valvular Heart Disease: executive summary: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"129","author":"Nishimura","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.thromres.2016.11.021_bb0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ejcts\/ezs455","volume":"42","author":"Vahanian","year":"2012","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"11","key":"10.1016\/j.thromres.2016.11.021_bb0015","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jacc.2012.06.014","article-title":"Prevention of thromboembolic events after bioprosthetic aortic valve replacement: what is the optimal antithrombotic strategy?","volume":"60","author":"Whitlock","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.thromres.2016.11.021_bb0020","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0735-1097(94)00563-6","article-title":"High risk of thromboemboli early after bioprosthetic cardiac valve replacement","volume":"25","author":"Heras","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.thromres.2016.11.021_bb0025","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0003-4975(94)00862-2","article-title":"Risk of thromboembolism with the aortic Carpentier-Edwards bioprosthesis","volume":"59","author":"Orszulak","year":"1995","journal-title":"Ann. Thorac. Surg."},{"issue":"6","key":"10.1016\/j.thromres.2016.11.021_bb0030","first-page":"667","article-title":"Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial","volume":"16","author":"Colli","year":"2007","journal-title":"J. Heart Valve Dis."},{"issue":"5","key":"10.1016\/j.thromres.2016.11.021_bb0035","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ejcts.2004.12.064","article-title":"Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial","volume":"27","author":"Aramendi","year":"2005","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"5","key":"10.1016\/j.thromres.2016.11.021_bb0040","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jtcvs.2004.11.028","article-title":"Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?","volume":"129","author":"Sundt","year":"2005","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"5","key":"10.1016\/j.thromres.2016.11.021_bb0045","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/01.CIR.0000137122.95108.52","article-title":"Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study","volume":"110","author":"Gherli","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2016.11.021_bb0050","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jtcvs.2009.10.064","article-title":"Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?","volume":"139","author":"ElBardissi","year":"2010","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.thromres.2016.11.021_bb0055","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jtcvs.2006.12.060","article-title":"Antiplatelet therapy in patients receiving aortic bioprostheses: a report of clinical and instrumental safety","volume":"133","author":"di Marco","year":"2007","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"11","key":"10.1016\/j.thromres.2016.11.021_bb0060","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jacc.2012.05.029","article-title":"Early anticoagulation of bioprosthetic aortic valves in older patients: results from the society of thoracic surgeons adult cardiac surgery national database","volume":"60","author":"Brennan","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"Suppl. 19","key":"10.1016\/j.thromres.2016.11.021_bb0065","first-page":"II95","article-title":"Anticoagulation is unnecessary after biological aortic valve replacement","volume":"98","author":"Moinuddeen","year":"1998","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.thromres.2016.11.021_bb0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/HCO.0000000000000259","article-title":"Anticoagulation for prosthetic heart valves: unresolved questions requiring answers","volume":"31","author":"Yanagawa","year":"2016","journal-title":"Curr. Opin. Cardiol."},{"issue":"20","key":"10.1016\/j.thromres.2016.11.021_bb0075","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1001\/jama.2012.54506","article-title":"Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding","volume":"308","author":"M\u00e9rie","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.thromres.2016.11.021_bb0080","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.athoracsur.2013.03.089","article-title":"Patient-prosthesis mismatch and reduction in left ventricular mass after aortic valve replacement","volume":"96","author":"Kandler","year":"2013","journal-title":"Ann. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.thromres.2016.11.021_bb0085","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.ijcard.2012.11.056","article-title":"Low-dose acetyl salicylic acid versus oral anticoagulation after bioprosthetic aortic valve replacement. Final report of the ACTION registry","volume":"168","author":"Colli","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.thromres.2016.11.021_bb0090","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/ejcts\/ezv254","article-title":"Antithrombotic strategy after bioprosthetic aortic valve replacement in patients in sinus rhythm: evaluation of guideline implementation","volume":"49","author":"van der Wall","year":"2016","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"15","key":"10.1016\/j.thromres.2016.11.021_bb0095","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jacc.2013.11.046","article-title":"New-onset atrial fibrillation after aortic valve replacement: comparison of transfemoral, transapical, transaortic, and surgical approaches","volume":"63","author":"Tanawuttiwat","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.thromres.2016.11.021_bb0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2459\/JCM.0b013e3283659f80","article-title":"A propensity-score matched analysis on the impact of postoperative atrial fibrillation on the early and late outcomes after concomitant aortic valve replacement and coronary artery bypass graft surgery","volume":"15","author":"Saxena","year":"2014","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"issue":"10","key":"10.1016\/j.thromres.2016.11.021_bb0105","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.thromres.2016.11.021_bb0110","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2016.11.021_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003839.pub2","article-title":"Self-monitoring and self-management of oral anticoagulation","volume":"4","author":"Garcia-Alamino","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.thromres.2016.11.021_bb0120","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1378\/chest.127.5.1515","article-title":"Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy","volume":"127","author":"Witt","year":"2005","journal-title":"Chest"},{"issue":"20","key":"10.1016\/j.thromres.2016.11.021_bb0125","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1161\/CIRCULATIONAHA.112.115410","article-title":"Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature","volume":"126","author":"Dentali","year":"2012","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.thromres.2016.11.021_bb0130","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.thromres.2016.11.021_bb0135","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1445-5994.2003.00360.x","article-title":"Effect of different aspirin doses on platelet aggregation in patients with stable coronary artery disease","volume":"33","author":"Malhotra","year":"2003","journal-title":"Intern. Med. J."},{"issue":"25","key":"10.1016\/j.thromres.2016.11.021_bb0140","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1161\/CIRCULATIONAHA.106.675587","article-title":"Evaluation of dose-related effects of aspirin on platelet function: results from the aspirin-induced platelet effect (ASPECT) study","volume":"115","author":"Gurbel","year":"2007","journal-title":"Circulation"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384816306417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384816306417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T11:24:38Z","timestamp":1536233078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384816306417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":28,"alternative-id":["S0049384816306417"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2016.11.021","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2016.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}